Kathy Geraets, MD
Family Medicine · Sioux Falls, SDNPI 1225472152
Payments from drug & device makers
Across 79 payments — averaging $15.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$213
- Pfizer$109
- Novo Nordisk$104
- Astellas Pharma US Inc$71
- Lilly USA, LLC$69
- Boehringer Ingelheim$49
- plus $628 from 29 others
What the payments were for
- Food & beverage$1,243100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 13 | $213 |
| Pfizer | 8 | $109 |
| Novo Nordisk | 6 | $104 |
| Astellas Pharma US Inc | 5 | $71 |
| Lilly USA, LLC | 4 | $69 |
| Boehringer Ingelheim | 3 | $49 |
| AbbVie | 2 | $49 |
| Daiichi Sankyo Inc. | 3 | $41 |
| Ultragenyx Pharmaceutical Inc. | 2 | $33 |
| AstraZeneca | 2 | $30 |
| Supernus Pharmaceuticals, Inc. | 2 | $30 |
| Sanofi-aventis U.S. LLC | 2 | $27 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $26 |
| Mylan Specialty L.p. | 2 | $25 |
| Amarin Pharma, Inc. | 2 | $25 |
| Biohaven Pharmaceuticals, Inc. | 2 | $25 |
| Novartis | 1 | $23 |
| The Binding Site Inc. | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $19 |
| Exeltis, USA Inc. | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Vertex | 1 | $16 |
| Abbott | 1 | $16 |
| Nabriva Therapeutics, PLC | 1 | $16 |
| Bayer | 1 | $16 |
| Medtronic | 1 | $16 |
| Corium, LLC | 1 | $16 |
| GSK | 1 | $15 |
| Merck | 1 | $14 |
| Dexcom, Inc. | 1 | $14 |
| Adlon Therapeutics L.p. | 1 | $13 |
| Johnson & Johnson | 1 | $12 |
| Gilead | 1 | $11 |
How this compares
$1,243 in reported general payments places this provider in the 85th percentile of 408 family medicine providers in South Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 30 | $38,787 |
| JardianceEmpagliflozin | 22 | $31,176 |
| XareltoRivaroxaban | 29 | $20,340 |
| EliquisApixaban | 23 | $20,216 |
| Repatha SureclickEvolocumab | 20 | $13,662 |
| MyrbetriqMirabegron | 16 | $11,086 |
| Incruse ElliptaUmeclidinium Bromide | 13 | $4,526 |
| Atorvastatin Calcium | 408 | $4,283 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 12 | $3,747 |
| Omeprazole | 234 | $2,902 |
| Rosuvastatin Calcium | 145 | $2,070 |
| Losartan Potassium | 174 | $1,824 |
| Gabapentin | 75 | $1,784 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 50 | $1,556 |
| Levothyroxine Sodium | 220 | $1,450 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $104 | $38,78730 claims |
| Boehringer IngelheimJardiance | $49 | $31,17622 claims |
| Johnson & JohnsonXarelto | $12 | $20,34029 claims |
| PfizerEliquis | $109 | $20,21623 claims |
| Astellas Pharma US IncMyrbetriq | $71 | $11,08616 claims |
| GSKIncruse Ellipta, Arexvy | $15 | $8,27325 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 408 family medicine providers in South Dakota.
Other family medicine in Sioux Falls
- Elizabeth JensenSioux Falls$106K
- Chad ThurySioux Falls$47K
- Andrew BurchettSioux Falls$13K
- Lornell HansenSioux Falls$11K
- Jeffry MeyerSioux Falls$8K
- Scott BoyensSioux Falls$6K
- Jason WurthSioux Falls$4K
- Dustin SnellingSioux Falls$4K
- William BuchnerSioux Falls$3K
- Jennifer SchrieverSioux Falls$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.